Use of opioid substitution therapies in the treatment of opioid use disorder: results of a UK cost-effectiveness modelling study-Reference-Cited by-同舟云学术

Use of opioid substitution therapies in the treatment of opioid use disorder: results of a UK cost-effectiveness modelling study

Published:2017-05-25 Issue:7 Volume:20 Page:740-748
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Kenworthy James¹,Yi Yunni²,Wright Antony²,Brown Jim²,Maria Madrigal Ana²,Dunlop William C. N.¹

Affiliation:

1. Mundipharma International Limited, Cambridge, UK;

2. PHMR, London, UK

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2017.1325744

Reference45 articles.

1. European Monitoring Centre for Drugs and Drug Addiction. United Kingdom country overview. 2016. http://www.emcdda.europa.eu/countries/united-kingdom#prevalence. Last accessed March 17, 2017

2. European Monitoring Centre for Drugs and Drug Addiction. European drug report 2016: trends and developments. Luxembourg: European Monitoring Centre for Drugs and Drug Addiction; 2016

3. European Monitoring Centre for Drugs and Drug Addiction. The state of the drugs problem in Europe. Annual report 2011. Luxembourg: European Monitoring Centre for Drugs and Drug Addiction; 2011

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analyzing quality of life among people with opioid use disorder from the National Institute on Drug Abuse Data Share initiative: implications for decision making;Quality of Life Research;2024-08-08

2. A Cross-sectional Study of Opioid Agonist Therapy Barriers and Facilitators;The Journal for Nurse Practitioners;2024-04

3. CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022;MMWR. Recommendations and Reports;2022-11-04

4. Long-acting injectable buprenorphine for opioid use disorder: A systematic review of impact of use on social determinants of health;Journal of Substance Abuse Treatment;2022-08

5. Examining the cost and impact of dosing fees among clients in opioid agonist treatment: Results from a cross‐sectional survey of Australian treatment clients;Drug and Alcohol Review;2022-02-07